论文部分内容阅读
目的:探究多囊卵巢综合征患者通过二甲双胍与达英-35联合治疗后所存在的应用价值。方法:选取我院收治的多囊卵巢综合征患者80例,且均在2014年1月-2016年6月诊治,依随机分组标准分为观察组(40人)和对照组(40人)。对照组为二甲双胍治疗,观察组在二甲双胍治疗的基础上联合达英-35治疗。从临床治疗有效率、性激素水平改善两方面入手,针对相关内容进行分析。结果:对照组治疗总有效率(77.5%)比观察组(92.5%)低(P<0.05);在性激素水平面,观察组治疗后优于对照组(P<0.05)。结论:多囊卵巢综合征患者通过二甲双胍与达英-35联合治疗后,在提高治疗效果的同时,使患者性激素水平显著改善,存在推广价值。
Objective: To investigate the value of the combination of metformin and da-Ying-35 in patients with polycystic ovary syndrome. Methods: Eighty patients with polycystic ovary syndrome who were treated in our hospital were enrolled in this study. All of them were diagnosed from January 2014 to June 2016 and divided into observation group (40 persons) and control group (40 persons) according to randomization criteria. The control group was treated with metformin. The observation group was treated with metformin on the basis of metformin treatment. From the clinical treatment of effective, the level of sex hormones to improve two aspects, for the relevant content analysis. Results: The total effective rate of the control group (77.5%) was lower than that of the observation group (92.5%) (P <0.05). On the level of sex hormones, the observation group was better than the control group after treatment (P <0.05). Conclusions: The combination of metformin and da-Ying-35 in patients with PCOS can improve the therapeutic effect and significantly improve the sex hormone level in patients with PCOS.